Lamassu Bio Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors (NCT06578624) | Lamassu Bio Inc | 2025-03-10 |
Track Lamassu Bio Inc automatically
Every clearance here is in the API, with alerts when new ones post.